From the preliminary statistical analysis, among the OHA- and insulin- combination treatments, biguanides and insulin were associated with rs17173608. Among the mono-therapy treatments, biguanides were associated with rs17173608 in T2D patients with CAD. This evidence concerns the gene INS and type 2 diabetes mellitus.